211 results
Page 3 of 11
424B5
3odaojv0ndy
18 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
hb3thb4 6gaosqy
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
j8d ayd0w4lji8rv5t
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
0nnej0850pf66wjlm
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
eez9g8iw h9u4i1
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
xupb cu4uu
8 Jun 15
Business combination disclosure
12:00am
425
xogq4
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
p6vrjkp328po 893zav
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
4s9hdl84pualihfrr
21 Apr 15
Business combination disclosure
12:00am
425
j9frd8xj1riz6z
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
okf7ka8fibwg
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
62ut16s92xjc6
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
EX-99.1
afn1dwjn5fx3xtqabfjf
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
w3b8 xy33vf
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
ihb eeegtl7cgqld7
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
etcjl
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
EX-99.1
pud5uaeabz4j dy
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
kxac 0wncencnetwl2
21 Jul 14
Live Filing
12:00am